Berardino De Bari

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


44 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
 
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/08. Journal of cancer research and clinical oncology, 145 (8) p. 2167. Peer-reviewed.
 
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/04. Journal of cancer research and clinical oncology, 145 (4) pp. 1075-1084. Peer-reviewed.
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
 
Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.
Conrad M., Bolard G., Nowak M., De Bari B., Jeanneret-Sozzi W., Bourhis J., Germond J.F., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 276-285. Peer-reviewed.
 
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B., Lestrade L., Franzetti-Pellanda A., Jumeau R., Biggiogero M., Kountouri M., Matzinger O., Miralbell R., Bourhis J., Ozsahin M. et al., 2018/04. Journal of cancer research and clinical oncology, 144 (4) pp. 781-789. Peer-reviewed.
 
Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase™ training tool.
De Bari B., Dahele M., Palmu M., Kaylor S., Schiappacasse L., Guckenberger M., ESTRO FALCON core, 2018/04. Radiotherapy and oncology, 127 (1) pp. 150-153. Peer-reviewed.
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report.
De Bari B., Vallati M., Gatta R., Lestrade L., Manfrida S., Carrie C., Valentini V., 2017/12/12. Oncotarget, 8 (65) pp. 108509-108521. Peer-reviewed.
 
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Pellanda A.F., De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., Villà S., Goldberg H., Szutowicz-Zielińska E., Bolla M. et al., 2017/12. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 29 (6) pp. 521-532. Peer-reviewed.
 
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Salas S., Resseguier N., Blay J.Y., Le Cesne A., Italiano A., Chevreau C., Rosset P., Isambert N., Soulie P., Cupissol D. et al., 2017/08/01. Annals of oncology, 28 (8) pp. 1979-1987. Peer-reviewed.
 
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Salas S., Resseguier N., Blay J.Y., Le Cesne A., Italiano A., Chevreau C., Rosset P., Isambert N., Soulie P., Cupissol D. et al., 2017/08/01. Annals of oncology, 28 (8) pp. 1979-1987. Peer-reviewed.
 
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
De Bari B., Stish B., Ball M.W., Habboush Y., Sargos P., Krengli M., Bossi A., Stabile A., Sole Pesutic C., Lestrade L. et al., 2017/07. The Prostate, 77 (10) pp. 1160-1166. Peer-reviewed.
 
Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.
Lestrade L., Zilli T., Kountouri M., Jumeau R., Matzinger O., Bourhis J., Miralbell R., Ozsahin M., De Bari B., 2017/07. Clinical oncology, 29 (7) pp. e105-e109. Peer-reviewed.
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
Herrmann E., Mertineit N., De Bari B., Hoeng L., Caparotti F., Leiser D., Jumeau R., Cihoric N., Jensen A.D., Aebersold D.M. et al., 2017/06/14. Radiation oncology, 12 (1) p. 97. Peer-reviewed.
 
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Castelli J., Depeursinge A., de Bari B., Devillers A., de Crevoisier R., Bourhis J., Prior J.O., 2017/06. Clinical nuclear medicine, 42 (6) pp. e281-e285. Peer-reviewed.
 
A PET-based nomogram for oropharyngeal cancers.
Castelli J., Depeursinge A., Ndoh V., Prior J.O., Ozsahin M., Devillers A., Bouchaab H., Chajon E., de Crevoisier R., Scher N. et al., 2017/04. European journal of cancer, 75 pp. 222-230. Peer-reviewed.
 
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer.
Jumeau R., Peguret N., de Bari B., Moeckli R., Soares-Rodrigues J.L., Durham A.D., Hojnowski S., Bourhis J., Ozsahin M., Beigelman-Aubry C., 2017/04. Journal of medical imaging and radiation oncology, 61 (2) pp. 252-257. Peer-reviewed.
 
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.
Alongi F., Arcangeli S., De Bari B., Giaj-Levra N., Fiorentino A., Mazzola R., Trovò M., 2017/03. Critical reviews in oncology/hematology, 112 pp. 67-71. Peer-reviewed.
 
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?
De Bari B., Durham A., Bourhis J., Ozsahin M., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 573-574. Peer-reviewed.
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Castelli J., De Bari B., Depeursinge A., Simon A., Devillers A., Roman Jimenez G., Prior J., Ozsahin M., de Crevoisier R., Bourhis J., 2016/12. Critical reviews in oncology/hematology, 108 pp. 40-51. Peer-reviewed.
 
Extreme hypofractionation for early prostate cancer: Biology meets technology.
De Bari B., Arcangeli S., Ciardo D., Mazzola R., Alongi F., Russi E.G., Santoni R., Magrini S.M., Jereczek-Fossa B.A., on the behalf of the Italian Association of Radiation Oncology (AIRO), 2016/11. Cancer treatment reviews, 50 pp. 48-60. Peer-reviewed.
 
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J., Navarro A., Del Hoyo O., Gomez-Iturriaga A., Alongi F., Medina J.A., Elicin O., Skanjeti A., Giammarile F., Bilbao P. et al., 2016/11. The British journal of radiology, 89 (1067) p. 20160217. Peer-reviewed.
 
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
De Bari B., Jumeau R., Deantonio L., Adib S., Godin S., Zeverino M., Moeckli R., Bourhis J., Prior J.O., Ozsahin M., 2016/10/13. Tumori, 102 (5) pp. e21-e24. Peer-reviewed.
 
Radiation Therapy for Extracranial Hemangiopericytoma/Solitary Fibrous Tumor: A Study From the Rare Cancer Network
Krengli M., De Bari B., Villa S., Kaanders J.H.A.M., Torrente S., Pasquier D., Thariat J.O., Myroslav L., Sole C.V., Dincbas H.F. et al., 2016/10. pp. E707 dans Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics, American Society for Radiation Oncology.
 
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?
Jereczek-Fossa B.A., Ciardo D., Petralia G., Bellomi M., De Bari B., De Cobelli O., Orecchia R., 2016/09. Critical reviews in oncology/hematology, 105 pp. 100-111. Peer-reviewed.
 
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
De Bari B., Porta L., Mazzola R., Alongi F., Wagner A.D., Schäfer M., Bourhis J., Ozsahin M., 2016/07. Critical reviews in oncology/hematology, 103 pp. 49-61. Peer-reviewed.
 
Traitement curatif du cancer de l'oesophage: consensus multidisciplinaire multicentrique [Curative treatment for esophageal cancer: results of a multidisciplinary consensus]
Allemann P., Mantziari S., Wagner D., Digklia A., Ozsahin E., De Bari B., Dorta G., Godat S., Montserrat F., Sempoux C. et al., 2016/06/15. Revue medicale suisse, 12 (523) pp. 1165-1169. Peer-reviewed.
 
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B., Jumeau R., Bouchaab H., Vallet V., Matzinger O., Troussier I., Mirimanoff R.O., Wagner A.D., Hanhloser D., Bourhis J. et al., 2016/06. Acta oncologica (Stockholm, Sweden), 55 (6) pp. 767-773. Peer-reviewed.
 
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.
De Bari B., Deantonio L., Bourhis J., Prior J.O., Ozsahin M., 2016/06. Critical reviews in oncology/hematology, 102 pp. 111-117. Peer-reviewed.
 
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?
Arcangeli S., Zilli T., De Bari B., Alongi F., 2016. Critical Reviews In Oncology/hematology, 97 pp. 231-237. Peer-reviewed.
 
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.
Arcangeli S., Ramella S., De Bari B., Franco P., Alongi F., D'Angelillo R.M., 2016. Critical Reviews In Oncology/hematology, 97 pp. 322-327. Peer-reviewed.
 
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
De Bari B., Ozsahin M., Bize P., Boussaha T., Deplanque G., Wagner D., Bourhis J., Denys A., 2016. Journal of Clinical Oncology, 34 (23) pp. 2798-2799. Peer-reviewed.
 
Prostatectomy vs radiation therapy for prostate cancer: The (still) unsolved dilemma.
De Bari B., Zietman A.L., Poortmans P., 2016. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 119 (2) p. 368. Peer-reviewed.
 
Spinal metastases: Is stereotactic body radiation therapy supported by evidences?
De Bari B., Alongi F., Mortellaro G., Mazzola R., Schiappacasse L., Guckenberger M., 2016. Critical Reviews In Oncology/hematology, 98 pp. 147-158. Peer-reviewed.
 
The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?
De Bari B., Franco P., Niyazi M., Cornetto A.P., Qvortrup C., Martin A.N., Cacicedo J., Fernandez G., Louro L.V., Lestrade L. et al., 2016. Technology In Cancer Research and Treatment, 15 (2) pp. 365-376. Peer-reviewed.
 
Cancer testiculaire: un modèle pour optimiser le suivi radiologique [Testicular cancer: a model to optimize the radiological follow-up].
Stebler V., Pauchard B., Schmidt S., Valerio M., De Bari B., Berthold D., 2015/05. Revue Médicale Suisse, 11 (475) pp. 1144-1148.
 
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B., Filippi A.R., Mazzola R., Bonomo P., Trovò M., Livi L., Alongi F., 2015. Cancer Treatment Reviews, 41 (6) pp. 511-518. Peer-reviewed.
 
Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.
De Bari B., Lestrade L., Pommier P., Maddalo M., Buglione M., Magrini S.M., Carrie C., 2015. Cancer Investigation, 33 (4) pp. 114-120. Peer-reviewed.
 
Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.
De Bari B., Vallati M., Gatta R., Simeone C., Girelli G., Ricardi U., Meattini I., Gabriele P., Bellavita R., Krengli M. et al., 2015. Cancer Investigation, 33 (6) pp. 232-240. Peer-reviewed.
 
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program.
Buglione M., Ghirardelli P., Triggiani L., Pedretti S., Pasinetti N., De Bari B., Tonoli S., Borghetti P., Spiazzi L., Magrini S.M., 2015. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 20 (4) pp. 284-291.
 
SBRT and extreme hypofractionation: A new era in prostate cancer treatments?
Alongi F., Fiorentino A., De Bari B., 2015. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 20 (6) pp. 411-416.
 
Re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur urol 2014;66:1024-30.
De Bari B., Alongi F., Arcangeli S., 2014. European Urology, 66 (6) pp. e111-e112.
 
Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
Lestrade L., De Bari B., Pommier P., Montbarbon X., Lavergne E., Ardiet J.M., Carrie C., 2014. Strahlentherapie Und Onkologie, 190 (6) pp. 546-554.
 
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias.
Arcangeli S., De Bari B., Alongi F., 2014. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 32 (30) p. 3454. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University